Disorder of Fluid Regulation in Geriatric Lita Septina Internist - Endocrine Metabolic and Diabetes List of Topic • Aging and Kidney Disease • Electrolyte Homeostasis • Osmoregulation Wang Deshun Renal Plasma Flow Decrease with Age Age specific glomerulosclerosis Urinary Creatinin Excretion as a function of Age Rosner Mitchel H, Geriatric Nephrology, 2018 Proposed Mechanism fo Aging Associated Kidney Disease Rosner Mitchel H, Geriatric Nephrology, 2018 Sodium Balance • Aging is associated with impaired excretion of a salt load and defective conservation in the setting of sodium restriction. • Proximal sodium reabsorption is increased in aging, whereas distal sodium reabsorption may be reduced. • Because the diet of most individuals in developed countries contains excess sodium (8 to 10 g of salt daily), there is a tendency in the elderly population for total body sodium excess : predisposing factors for of hypertension • Loss of vascular compliance lead to endothelial dysfunction, perhaps mediated by oxidative stress. • Aging- associated renal and vascular changes may explain why correction of secondary forms of hypertension (e.g., primary aldosteronism, Cushing syndrome, and renovascular hypertension) is less effective at curing hypertension in older patients. Rosner Mitchel H, Geriatric Nephrology, 2018 Sodium Homeostasis • Hypo and hypernatremia are disorders of water balance Hyponatremia usually suggests too much water in the ECF relative to Na+ content Hypernatremia usually suggests too little water in the ECF relative to Na+ content • Solutes (such as Na+, K+, glucose) that cannot freely traverse the plasma membrane contribute to effective osmolality and induce transcellular shifts of water water moves out of cells in response to increased ECF osmolality water moves into cells in response to decreased ECF osmolality • ECF volume is determined by Na+ content rather than concentration Na+ deficiency leads to ECF volume contraction Na+ excess leads to ECF volume expansion • Clinical signs and symptoms of hyponatremia and hypernatremia are secondary to cells (especially in the brain) shrinking (hypernatremia) or swelling (hyponatremia) ECF = Extra cellular fluid Endocrine Subspeciality Consult 3rd Ed, 2013 Clinical Assessment of ECF Volume (Total Body Na+) Toronto Notes 2016 Hyponatraemia Approach to hyponatremia Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Shah Beejal, Conn’s Curent Therapy 2016 Signsand Symptoms • Hyponatremia = swollen cells • Acute hyponatremia (<24-48 h) more likely to be symptomatic • Chronic hyponatremia (>24-48 h) less likely to be symptomatic due to adaptation adaptation: normalization of brain volume through loss of cellular electrolytes (within hours) and organic osmolytes (within days) adaptation is responsible for the risks associated with overly rapid correction • Neurologic symptoms predominate (secondary to cerebral edema): headache, nausea, malaise, lethargy, weakness, muscle cramps, anorexia, somnolence, disorientation, personality changes, depressed reflexes, decreased LOC (loss of consciousness) Endocrine, Therapuetic Guidelines 2014 Complication of Hyponatremia • Seizures, coma, respiratory arrest, permanent brain damage, brainstem herniation, death • Risk of brain cell shrinkage with rapid correction of hyponatremia can develop osmotic demyelination of pontine and extrapontine neurons; may be irreversible (e.g. central pontine myelinolysis: cranial nerve palsies, quadriplegia, decreased LOC) Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Endocrine Subspeciality Consult 3rd Ed, 2013 Investigation • ECF volume status assessment • Serum electrolytes, glucose, Cr • Serum osmolality, urine osmolality • Urine Na+ (urine Na+ <10-20 mmol/L suggests volume depletion as the cause of hyponatremia) • assess for causes of SIADH • TSH, free T4, and cortisol levels •Consider CXR andpossibly CT chest if suspect pulmonary cause of SIADH (e.g.small cell lung cancer) • Consider CT head if suspect CNS cause of SIADH Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Treatment General measures for all patients 1) treat underlying cause (e.g. restore ECF volume if volume depleted, remove o ending drug, treat pain, nausea, etc.) 2) restrict free water intake 3) promote free water loss 4) carefully monitor serum Na+ , urine volume, and urine tonicity 5) ensure frequently that correction is not occurring too rapidly Monitor urine output frequently: high output of dilute urine is the first sign of dangerously rapid correction of hyponatremia Rapid correcting may produced permanent central nervous system injury due to osmotic demyelination. Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Impact of IV Solution on Serum [Na+] TBW = Total Body Water LR : lactate Ringer Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Pccket Medicine 6Ed, 2017 Reference, medcape .com Hypernatraemia Approach to hypernatremia Marx J et al [eds]: Rosen's emergency medicine: concepts and clinical practice, ed 6, St Louis, 2006, Mosby Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Signs and Symptoms • With acute hypernatremia no time for adaptation, therefore more likely to be symptomatic • Adaptive response: cells import and generate new osmotically active particles to normalize size • Due to brain cell shrinkage: altered mental status, weakness, neuromuscular irritability, focal neurologic deficits, seizures, coma, death • ± polyuria, thirst, signs of hypovolemia Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Endocrine Subspeciality Consult 3rd Ed, 2013 Complication Hypernatremia • Increased risk of vascular rupture resulting in intracranial hemorrhage • Rapid correction may lead to cerebral edema due to ongoing brain hyperosmolality Endocrine Subspeciality Consult 3rd Ed, 2013 Treatment Hypernatremia • General measures for all patients give free water (oral or IV) treat underlying cause monitor serum Na+ frequently to ensure correction is not occurring too rapidly • If evidence of hemodynamic instability, must first correct volume depletion with NS bolus • Loss of water is o en accompanied by loss of Na+, but a proportionately larger water loss • Use formula to calculate free water H2O deficit and replace • Encourage patient to drink pure water, as oral route is preferred for fluid administration • If unable to replace PO or NG, correct H2O deficit with hypotonic IV solution (IV D5W, 0.45% NS [half normal saline], or 3.3% dextrose with 0.3% NaCl [“2/3 and 1/3”]) • Aim to lower [Na+] by no more than 12 mmol/L in 24 h (0.5 mmol/L/h) • Must also provide maintenance fluids and replace ongoing losses • General rule: give 2 cc/kg/h of free water to correct serum [Na+] by about 0.5 mmol/L/h or 12 mmol/L/d Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Hypokalemia Na+ reabsorption and K+ excretion • metabolic alkalosis (increases K+ secretion) • hypomagnesemia • increased non-reabsorbable anions in tubule lumen: HCO3-, penicillin, salic tubular ow rate increases K+ secretion) Hy p o k alem ia Sympt ms Signs and • serum [K+] <3.5 mEq/L Depressed ST segment Prolongation of Q-T interval 1 Normal 2 U wave 3 U wave progression 4 © Andrea Cormier Signs and Symptoms • usually asymptomatic, particularly when mild (3.0-3.5 mmol/L) • N/V, fatigue, generalized weakness, myalgia, muscle cramps, and constipati • Usually asymptomatic, particularly when mild (3.0-3.5 mEq/L) muscle necrosis, and rarely paralysis with eventual re • if severe: arrhythmias, • Fatigue, generalized weakness, myalgia, muscle cramps, and constipation impairment arrhythmias occur at variable levels of K+; more likely if digoxin use, hypom • If severe: arrhythmias, muscle necrosis, and•rarely paralysis with eventual respiratory impairment + [K+] • ECG changes are more predictive of clinical picture than serum • Arrhythmias occur at variable levels of K ; more U likely ifmost digoxin use, hypomagnesemia, CAD •aECG waves important (low amplitude waveor following T wave) +] T waves changes are more predictive of clinical picture than attened serum or [Kinverted depressed ST segment U waves most important (low amplitude wave following a Tinterval wave) prolongation of Q-T with severe hypokalemia: P-R prolongation, wide QRS, arrhythmias; inc Flattened or inverted T waves digitalis toxicity Figure 6. ECG changes in hypokalemia With severe hypokalemia: P-R prolongation, wide QRS, arrhythmias; increases risk of digitalis toxicity Endocrine Subspeciality Consult 3rd Ed, 2013 The diagnostic approach to hypokalemia Abbreviations: ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; ENAC = epithelial sodium channel; GFR = glomerular filtration rate; NSAIDS = nonsteroidal anti-inflammatory drugs; RTA = renal tubular acidosis; TTKG = transtubular K Tang Jie,Hypokalemia and Hypekalemia, Conn Current Teraphy, 2016 gradient. Approach to hypokalemia BP, Blood pressure; GI, gastrointestinal; GRA, glucose remediable aldosteronism; RTA, renal tubular acidosis. Feehally J, Floege J, Johnson RJ: Comprehensive clinical • Treat underlying cause Treatment • If true K+ deficit, potassium repletion (decrease in serum [K+] of 1 mEq is roughly 100-200 mEq of total body loss) oral sources – food, tablets (KSR, Aspar K), KCl liquid solutions (preferable route if the patient tolerates PO medications) IV – usually KCl in saline solutions, avoid dextrose solutions (may exacerbate hypokalemia via insulin release) max 40 mmol/L via peripheral vein, 60 mmol/L via central vein, max infusion 20 mmol/h • K+-sparing diuretics (triamterene, spironolactone, amiloride) can prevent renal K+ loss • Restore Mg2+ if necessary • If urine output and renal function are impaired, correct with extreme caution • Risk of hyperkalemia with potassium replacement especially high in elderly, diabetics, and patients with decreased renal function • Beware of excessive potassium repletion, especially if transcellular shi caused hypokalemia Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Hyperkalemia Signs and Symptoms • Usually asymptomatic but may develop nausea, palpitations, muscle weakness, muscle stiffness, paresthesias, areflexia, ascending paralysis, and hypoventilation • Impaird renal ammoniagenesis and metabolic acidosis • ECG changes and cardiotoxicity (do not correlate well with serum [K+]) peaked and narrow T waves decreased amplitude and eventual loss of P waves prolonged PR interval widening of QRS and eventual merging with T wave (sine-wave pattern) AV block ventricular fibrillation, asystole Endocrine Subspeciality Consult 3rd Ed, 2013 Clinical Assessment of Hyperkalamia Causes of Hyperkalemia Causes of Hyperkalemia with normal GFR Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 The diagnostic approach to hyperkalemia *Hyperkalemia may occur with higher GFR if K load is excessive. Abbreviations: ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; ENAC = epithelial sodium channel; GFR = glomerular filtration rate; NSAIDS = nonsteroidal anti-inflammatory drugs; RTA = renal tubular acidosis; TTKG = transtubular K gradient. Tang Jie,Hypokalemia and Hypekalemia, Conn Current Teraphy, 2016 Treatment • Acute therapy is warranted if ECG changes are present or if patient is symptomatic • Tailor therapy to severity of increase in [K+] and ECG changes [K+] <6.5 and normal ECG • Treat underlying cause, stop K+ intake, increase the loss of K+ via urine and/or GI tract [K+] between 6.5 and 7.0, no ECG changes: add insulin to above regimen [K+] >7.0 and/or ECG changes: first priority is to protect the heart, add calcium gluconate to above 1. Protect the heart 2. Shift K into Cells + 3. Enhance K Removal from Body + Toronto Notes 2016 Endocrine, Therapuetic Guidelines 2014 Endocrine Subspeciality Consult 3rd Ed, 2013 Clinical Consideration in the Assessment of Emergency Geriatric Patient Barnett SR. Manual of Geriatric Anesthesia. New York: Springer; 2013. Prevention Acute Kidney Injury in ICU Chronopoulos A, et al. Intensive Hope of Asian Wassalamualaikum ww